Skip to content

Accuracy and Reliability of Novii: Fetal Heart Rate (FHR), Maternal Heart Rate (MHR) and Uterine Contraction (UA) Compared With Doppler, Scalp Fetal Scalp Electrode (FSE), Tocodynamometer (TOCO) and Intra Uterine Pressure Catheter (IUPC)

Accuracy and Reliability of a New Intrapartum Fetal Heart Rate, Maternal Heart Rate, and Uterine Contraction Monitoring Method Compared With Food and Drug Administration (FDA) Approved Techniques.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03409146
Enrollment
80
Registered
2018-01-24
Start date
2014-05-28
Completion date
2017-02-13
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Term Labour

Brief summary

Accuracy and Reliability of the Novii device (fetal heart rate, maternal heart rate and uterine activity) compared with Food and Drug Administration (FDA) approved techniques

Detailed description

The study is being done to test the performance of a Novii Wireless Patch System for following the baby's and mother's heart rates and uterine contractions during labor. We want to find out if the new monitor works as well as other types of monitors that are usually used: Doppler Fetal Heart Rate (FHR), Scalp FHR, Tocodynamometer (TOCO) and Intra Uterine Pressure Catheter (IUPC). 80 patients will be monitored during the study.

Interventions

DEVICEMonica Novii Wireless Patch System

The Monica Novii Wireless Patch System is a transabdominal fetal/maternal recorder that provides fetal heart rate, maternal heart rate and maternal uterine activity contractions.

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

A woman will be considered for inclusion in the study if she fulfills all of the following criteria: * She has a term or near term (≥36 completed weeks) singleton gestation in a cephalic presentation and has been admitted to the Labor and Delivery Unit . * She is in the latent phase of spontaneous labor, or has been admitted for induction of labor. * She has given her informed consent to participate as a subject. * She has none of the

Exclusion criteria

.

Design outcomes

Primary

MeasureTime frameDescription
Fetal Heart Rate (FHR) Positive Percentage Agreement (PPA)through study completion, an average of 1 yearPPA(%)=(a/(a+C))x100, where a represents the number of 2 second epochs when the Novii FHR is within +/-10% of the predicate device FHR for each 2 second epoch, and c are the number of 2 second epochs when the Novii FHR is not within +/- 10% of the predicate device FHR or is absent.

Secondary

MeasureTime frameDescription
Mean Percentage FHR Equivalencethrough study completion, an average of 1 yearThe 2 second output FHR data when both the predicate and Novii devices are reporting a value will be considered. In this case for each 2 second epoch the FHR value from the Novii device is divided by the predicate device FHR value to create a FHR ratio.
Uterine Activity (UA) Sensitivity (from Individual Contractions)through study completion, an average of 1 yearThe Sensitivity of the Novii System against the predicate device is determined from the individual contraction detection as follows: Sensitivity(%)=(x/(x+z))x100 Where: x is the total number of individual contractions detected by both the devices z is the total number of individual contractions detected by the predicate device only
Uterine activity Positive Percentage Agreement (from Interpretable Data)through study completion, an average of 1 yearThe positive percentage agreement (PPA) is determined from the interpretable and uninterpretable data as follows: PPA(%)=(a/(a+c))x100 Where: a is the number of minutes when both devices UA are interpretable at the same time c is the number of minutes when the predicate device UA is interpretable but the Novii system UA is un-interpretable.
Maternal Heart Rate (MHR) Positive Percentage Agreement (PPA)through study completion, an average of 1 yearPPA(%)=(a/(a+C))x100, where a represents the number of 2 second epochs when the Novii MHR is within +/-10% of the predicate device MHR for each 2 second epoch, and c are the number of 2 second epochs when the Novii MHR is not within +/- 10% of the predicate device MHR or is absent.
Mean Percentage MHR Equivalencethrough study completion, an average of 1 yearThe 2 second output MHR data when both the predicate and Novii devices are reporting a value will be considered. In this case for each 2 second epoch the MHR value from the Novii device is divided by the predicate device MHR value to create a MHR ratio.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026